TAURIGA SCIENCES, INC. (OTCMKTS:TAUG) Files An 8-K Entry into a Material Definitive Agreement

0
TAURIGA SCIENCES, INC. (OTCMKTS:TAUG) Files An 8-K Entry into a Material Definitive Agreement

TAURIGA SCIENCES, INC. (OTCMKTS:TAUG) Files An 8-K Entry into a Material Definitive Agreement
ITEM 1.01 Entry into a Material Definitive Agreement

On June 28, 2019, Tauriga Sciences, Inc. (OTCQB stock symbol: TAUG, the “Company”) entered into a distribution agreement (the “Agreement”) with Windmill Health Products, LLC (“WHP”), a New Jersey based distributor, with the intention of increasing and accelerating market penetration of the Company’s Tauri-GumTM product line.

Simultaneous with the Company’s entry into the WHP Agreement, WHP placed an initial purchase order with us totaling $46,848, split evenly between packages of our Mint flavored and Blood-Orange flavored chewing gum product lines.

The Company is not contributing any capital or issuing any equity to WHP in connection this Agreement, as this arrangement provides for an arms-length supplier-distributor model on a purchase order basis.

The WHP Agreement also contains customary representations, warranties and covenants, among other terms, for a transaction of this type. The foregoing description of the WHP Agreement is not complete and is qualified in its entirety by reference to the provisions of the WHP Agreement filed as Exhibit 10.1 to this Current Report on Form 8-K, and which is incorporated herein by reference.

Item 9.01 Exhibits Statements and Exhibits

(d) Exhibits

Exhibit Number Description
10.1 Distribution Agreement between the Company and Windmill Health Products, LLC, dated June 28, 2019


TAURIGA SCIENCES, INC. Exhibit
EX-10.1 2 ex10-1.htm   DISTRIBUTION AGREEMENT   THIS DISTRIBUTION AGREEMENT (the “Agreement”) is made effective as of the Effective Date between the Company and the Client,…
To view the full exhibit click here

About TAURIGA SCIENCES, INC. (OTCMKTS:TAUG)

Tauriga Sciences, Inc. is a diversified company. The Company is focused on the development of technology platform in the nano-robotics space. The Company is engaged in acquiring and building a portfolio of technology assets.